These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8867897)

  • 21. Inhibition of platelet adhesion and thrombus formation on a collagen-coated surface by novel carbamoylpiperidine antiplatelet agents.
    Alevriadou BR; McIntire LV; Lasslo A
    Biochim Biophys Acta; 1992 Nov; 1137(3):279-86. PubMed ID: 1445929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
    Edgington TS; Dickinson CD; Ruf W
    Thromb Haemost; 1997 Jul; 78(1):401-5. PubMed ID: 9198187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The factor VIIa/tissue factor complex.
    Banner DW
    Thromb Haemost; 1997 Jul; 78(1):512-5. PubMed ID: 9198205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
    Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
    Han G; Bannerman D; Handa RK; Dillingham EO; Lawrence WH; Gollamudi R
    Gen Pharmacol; 1997 Apr; 28(4):617-21. PubMed ID: 9147034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The quest for Factor VIIa exosite inhibitors.
    Amour A; Hutchinson J; Ruiz Avendaño AM; Ratcliffe S; Alvarez E; Martin J; Toomey JR; Senger S; Wolfendale M; Mooney C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):555-8. PubMed ID: 17511650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor.
    Andree HA; Contino PB; Repke D; Gentry R; Nemerson Y
    Biochemistry; 1994 Apr; 33(14):4368-74. PubMed ID: 8155655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.
    Gajsiewicz JM; Nuzzio KM; Rienstra CM; Morrissey JH
    Biochemistry; 2015 Aug; 54(30):4665-71. PubMed ID: 26169722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
    Banner DW; D'Arcy A; Chène C; Winkler FK; Guha A; Konigsberg WH; Nemerson Y; Kirchhofer D
    Nature; 1996 Mar; 380(6569):41-6. PubMed ID: 8598903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC; Jiang X
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.
    Riewald M; Ruf W
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7742-7. PubMed ID: 11438726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of recombinant factor VIIa with platelet glycoprotein Ib.
    Lisman T; de Groot PG
    Thromb Res; 2010 Apr; 125 Suppl 1():S13-5. PubMed ID: 20153024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1227-33. PubMed ID: 15504346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.